Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6237628rdf:typepubmed:Citationlld:pubmed
pubmed-article:6237628lifeskim:mentionsumls-concept:C0124604lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0018894lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0814999lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0007589lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0038856lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1155229lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1135166lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1366556lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1705513lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1422172lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1305923lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0200932lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C1511938lld:lifeskim
pubmed-article:6237628lifeskim:mentionsumls-concept:C0067787lld:lifeskim
pubmed-article:6237628pubmed:issue2lld:pubmed
pubmed-article:6237628pubmed:dateCreated1984-11-9lld:pubmed
pubmed-article:6237628pubmed:abstractTextNormal mice given thymocyte subpopulations preincubated with a proline-rich polypeptide (PRP) and immunized with SRBC show enhanced or suppressed humoral immune response measured by the number of plaque-forming cells (PFC). PRP induces differentiation of cells exhibiting helper or suppressive function from NAT and GAT respectively. Moreover, it was demonstrated that PRP-induced helper cells lost their activity after treatment with anti-Lyt 1,1 and the PRP-induced suppressor cells after treatment with anti-Lyt 2,1 monoclonal antibodies.lld:pubmed
pubmed-article:6237628pubmed:languageenglld:pubmed
pubmed-article:6237628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237628pubmed:citationSubsetIMlld:pubmed
pubmed-article:6237628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6237628pubmed:statusMEDLINElld:pubmed
pubmed-article:6237628pubmed:issn0004-069Xlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:WieczorekZZlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:LisowskiJJlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:JanuszMMlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:Staro?cikKKlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:ZimeckiMMlld:pubmed
pubmed-article:6237628pubmed:authorpubmed-author:Hrab?TTlld:pubmed
pubmed-article:6237628pubmed:issnTypePrintlld:pubmed
pubmed-article:6237628pubmed:volume32lld:pubmed
pubmed-article:6237628pubmed:ownerNLMlld:pubmed
pubmed-article:6237628pubmed:authorsCompleteYlld:pubmed
pubmed-article:6237628pubmed:pagination197-201lld:pubmed
pubmed-article:6237628pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:meshHeadingpubmed-meshheading:6237628-...lld:pubmed
pubmed-article:6237628pubmed:year1984lld:pubmed
pubmed-article:6237628pubmed:articleTitleThe effect of a proline-rich polypeptide (PRP) on the humoral immune response. II. PRP induces differentiation of helper cells from glass-nonadherent thymocytes (NAT) and suppressor cells from glass-adherent thymocytes (GAT).lld:pubmed
pubmed-article:6237628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6237628pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed